Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2020 4
2021 2
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
STARRT-AKI Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group; United Kingdom Critical Care Research Group; Canadian Nephrology Trials Network; Irish Critical Care Trials Group; Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, Du B, Gallagher MP, Gaudry S, Hoste EA, Lamontagne F, Joannidis M, Landoni G, Liu KD, McAuley DF, McGuinness SP, Neyra JA, Nichol AD, Ostermann M, Palevsky PM, Pettilä V, Quenot JP, Qiu H, Rochwerg B, Schneider AG, Smith OM, Thomé F, Thorpe KE, Vaara S, Weir M, Wang AY, Young P, Zarbock A. STARRT-AKI Investigators, et al. N Engl J Med. 2020 Jul 16;383(3):240-251. doi: 10.1056/NEJMoa2000741. N Engl J Med. 2020. PMID: 32668114 Free article. Clinical Trial.
Whole-genome sequencing reveals host factors underlying critical COVID-19.
Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams CA, Walker S, Russell CD, Malinauskas T, Wu Y, Millar J, Shen X, Elliott KS, Griffiths F, Oosthuyzen W, Morrice K, Keating S, Wang B, Rhodes D, Klaric L, Zechner M, Parkinson N, Siddiq A, Goddard P, Donovan S, Maslove D, Nichol A, Semple MG, Zainy T, Maleady-Crowe F, Todd L, Salehi S, Knight J, Elgar G, Chan G, Arumugam P, Patch C, Rendon A, Bentley D, Kingsley C, Kosmicki JA, Horowitz JE, Baras A, Abecasis GR, Ferreira MAR, Justice A, Mirshahi T, Oetjens M, Rader DJ, Ritchie MD, Verma A, Fowler TA, Shankar-Hari M, Summers C, Hinds C, Horby P, Ling L, McAuley D, Montgomery H, Openshaw PJM, Elliott P, Walsh T, Tenesa A; GenOMICC investigators; 23andMe investigators; COVID-19 Human Genetics Initiative; Fawkes A, Murphy L, Rowan K, Ponting CP, Vitart V, Wilson JF, Yang J, Bretherick AD, Scott RH, Hendry SC, Moutsianas L, Law A, Caulfield MJ, Baillie JK. Kousathanas A, et al. Nature. 2022 Jul;607(7917):97-103. doi: 10.1038/s41586-022-04576-6. Epub 2022 Mar 7. Nature. 2022. PMID: 35255492 Free PMC article.
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM; PRECISION Trial Investigators. Nissen SE, et al. N Engl J Med. 2016 Dec 29;375(26):2519-29. doi: 10.1056/NEJMoa1611593. Epub 2016 Nov 13. N Engl J Med. 2016. PMID: 27959716 Free article. Clinical Trial.
Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [(18)F]AmBF(3)-TATE.
Lau J, Pan J, Rousseau E, Uribe CF, Seelam SR, Sutherland BW, Perrin DM, Lin KS, Bénard F. Lau J, et al. EJNMMI Res. 2020 Mar 19;10(1):25. doi: 10.1186/s13550-020-0611-9. EJNMMI Res. 2020. PMID: 32189151 Free PMC article.
At 1 h p.i., the pancreas (F, 15.7 3.72 and M 14.3 1.61 %ID/g), stomach (F, 15.3 3.63 and M, 19.0 3.49 %ID/g), and lungs (F, 9.26 2.24 and M, 6.17 6.04 %ID/g) were the organs with the highest specific uptake. Pre-injection with [(19)F]AmBF(3)-TATE sign …
At 1 h p.i., the pancreas (F, 15.7 3.72 and M 14.3 1.61 %ID/g), stomach (F, 15.3 3.63 and M, 19.0 3.49 %ID/g), and lungs (F …
Extreme hydrothermal conditions at an active plate-bounding fault.
Sutherland R, Townend J, Toy V, Upton P, Coussens J, Allen M, Baratin LM, Barth N, Becroft L, Boese C, Boles A, Boulton C, Broderick NGR, Janku-Capova L, Carpenter BM, Célérier B, Chamberlain C, Cooper A, Coutts A, Cox S, Craw L, Doan ML, Eccles J, Faulkner D, Grieve J, Grochowski J, Gulley A, Hartog A, Howarth J, Jacobs K, Jeppson T, Kato N, Keys S, Kirilova M, Kometani Y, Langridge R, Lin W, Little T, Lukacs A, Mallyon D, Mariani E, Massiot C, Mathewson L, Melosh B, Menzies C, Moore J, Morales L, Morgan C, Mori H, Niemeijer A, Nishikawa O, Prior D, Sauer K, Savage M, Schleicher A, Schmitt DR, Shigematsu N, Taylor-Offord S, Teagle D, Tobin H, Valdez R, Weaver K, Wiersberg T, Williams J, Woodman N, Zimmer M. Sutherland R, et al. Nature. 2017 Jun 1;546(7656):137-140. doi: 10.1038/nature22355. Epub 2017 May 17. Nature. 2017. PMID: 28514440 Free article.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R, McDonald TJ, Lamb CA, Sebastian S, Kok K, Lees CW, Hart AL, Pollok RC, Boyton RJ, Altmann DM, Pollock KM, Goodhand JR, Kennedy NA, Ahmad T, Powell N; CLARITY study investigators. Liu Z, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. doi: 10.1016/S2468-1253(22)00389-2. Epub 2022 Dec 5. Lancet Gastroenterol Hepatol. 2023. PMID: 36481043 Free PMC article.
FUNDING: Royal Devon University Healthcare NHS Foundation Trust; Hull University Teaching Hospital NHS Trust; NIHR Imperial Biomedical Research Centre; Crohn's and Colitis UK; Guts UK; National Core Studies Immunity Programme, UK Research and Innovation; and unrestricted educatio …
FUNDING: Royal Devon University Healthcare NHS Foundation Trust; Hull University Teaching Hospital NHS Trust; NIHR Imperial Biomedical Resea …
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421
In COVID-19 Health Messaging, Loss Framing Increases Anxiety with Little-to-No Concomitant Benefits: Experimental Evidence from 84 Countries.
Dorison CA, Lerner JS, Heller BH, Rothman AJ, Kawachi II, Wang K, Rees VW, Gill BP, Gibbs N, Ebersole CR, Vally Z, Tajchman Z, Zsido AN, Zrimsek M, Chen Z, Ziano I, Gialitaki Z, Ceary CD, Lin Y, Kunisato Y, Yamada Y, Xiao Q, Jiang X, Du X, Yao E, Wilson JP, Cyrus-Lai W, Jimenez-Leal W, Law W, Collins WM, Richard KL, Vranka M, Ankushev V, Schei V, Križanić V, Kadreva VH, Adoric VC, Tran US, Yeung SK, Hassan W, Houston R, Lima TJS, Ostermann T, Frizzo T, Sverdrup TE, House T, Gill T, Fedotov M, Paltrow T, Jernsäther T, Koptjevskaja-Tamm M, Hostler TJ, Ishii T, Szaszi B, Adamus S, Suter L, Habib S, Studzinska A, Stojanovska D, Janssen SMJ, Stieger S, Schulenberg SE, Tatachari S, Azouaghe S, Sorokowski P, Sorokowska A, Song X, Lewis SC, Sinkolova S, Grigoryev D, Drexler SM, Daches S, Geniole SN, Vračar S, Massoni S, Zorjan S, Sarıoğuz E, Izquierdo SM, Alves SG, Pöntinen S, Solas SÁ, Ordoñez-Riaño S, Očovaj SB, Onie S, Lins S, Çoksan S, Sacakli A, Ruiz-Fernández S, Geiger SJ, FatahModares S, Walczak RB, Betlehem R, Vilar R, Cárcamo R, Ross RM, McCarthy R, Ballantyne T, Westgate EC, Afhami R, Ren D, Monteiro RP, Reips UD, Reggev N, Calin-Jageman RJ, Pourafshari R, Oliveira R, Nedelcheva… See abstract for full author list ➔ Dorison CA, et al. Affect Sci. 2022 Sep 26;3(3):577-602. doi: 10.1007/s42761-022-00128-3. eCollection 2022 Sep. Affect Sci. 2022. PMID: 36185503 Free PMC article.
Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes.
Lin BH, Sutherland MR, Rosell FI, Morrissey JH, Pryzdial ELG. Lin BH, et al. J Thromb Haemost. 2020 Jun;18(6):1370-1380. doi: 10.1111/jth.14790. Epub 2020 Apr 9. J Thromb Haemost. 2020. PMID: 32145149 Free PMC article.
BACKGROUND: The cell membrane-derived initiators of coagulation, tissue factor (TF) and anionic phospholipid (aPL), are constitutive on the herpes simplex virus type 1 (HSV1) surface, bypassing physiological regulation. TF and aPL accelerate proteolytic activation of factor (F …
BACKGROUND: The cell membrane-derived initiators of coagulation, tissue factor (TF) and anionic phospholipid (aPL), are constitutive on the …
13 results